FR1525186A
(fr)
|
1967-03-29 |
1968-05-17 |
Roussel Uclaf |
Nouvelles pénicillines et procédé de préparation
|
DE3065190D1
(en)
|
1979-11-05 |
1983-11-10 |
Beecham Group Plc |
Enzyme derivatives, and their preparation
|
DE4034829A1
(de)
|
1990-11-02 |
1992-05-07 |
Merck Patent Gmbh |
Cyclopeptide
|
JP3190431B2
(ja)
|
1991-07-01 |
2001-07-23 |
三菱化学株式会社 |
ケトン誘導体
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
WO1996034010A2
(en)
|
1995-03-29 |
1996-10-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5624936A
(en)
|
1995-03-29 |
1997-04-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5869682A
(en)
|
1996-04-03 |
1999-02-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
AU717298B2
(en)
|
1996-04-03 |
2000-03-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
PE121699A1
(es)
|
1997-02-18 |
1999-12-08 |
Boehringer Ingelheim Pharma |
Heterociclos biciclicos disustituidos como inhibidores de la trombina
|
ZA985247B
(en)
|
1997-06-19 |
1999-12-17 |
Du Pont Merck Pharma |
Guanidine mimics as factor Xa inhibitors.
|
TW557297B
(en)
|
1997-09-26 |
2003-10-11 |
Abbott Lab |
Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same
|
KR100928878B1
(ko)
|
1998-03-19 |
2009-11-30 |
버텍스 파마슈티칼스 인코포레이티드 |
카스파제의 억제제
|
ES2310039T3
(es)
|
1998-05-26 |
2008-12-16 |
Warner-Lambert Company Llc |
Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular.
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
HUP0105437A3
(en)
|
1999-01-02 |
2003-03-28 |
Aventis Pharma Gmbh |
Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
|
EP1016663A1
(en)
|
1999-01-02 |
2000-07-05 |
Aventis Pharma Deutschland GmbH |
Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
|
SK14232001A3
(sk)
|
1999-04-09 |
2002-06-04 |
Basf Aktiengesellschaft |
Nízkomolekulové inhibítory komplementárnych proteáz
|
AU5413600A
(en)
|
1999-06-14 |
2001-01-02 |
Eli Lilly And Company |
Compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
EP1125925A1
(en)
|
2000-02-15 |
2001-08-22 |
Applied Research Systems ARS Holding N.V. |
Amine derivatives for the treatment of apoptosis
|
CA2408486A1
(en)
|
2000-05-11 |
2001-11-15 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
AR035216A1
(es)
|
2000-12-01 |
2004-05-05 |
Astrazeneca Ab |
Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
|
AU2002322802A1
(en)
|
2001-07-27 |
2003-02-17 |
Merck And Co., Inc. |
Thrombin inhibitors
|
US6951840B2
(en)
|
2001-08-31 |
2005-10-04 |
Eli Lilly And Company |
Lipoglycopeptide antibiotics
|
BRPI0212726B8
(pt)
|
2001-09-21 |
2021-05-25 |
Bristol Myers Squibb Co |
compostos contendo lactamas, e derivados dos mesmos, composição farmacêutica que os compreende e seus usos
|
WO2003041641A2
(en)
|
2001-11-09 |
2003-05-22 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
|
WO2003106438A1
(en)
|
2002-06-18 |
2003-12-24 |
The Scripps Research Institute |
Synthesis of diazonamide "a" core
|
US20040180855A1
(en)
|
2003-02-19 |
2004-09-16 |
Schumacher William A. |
Methods of treating thrombosis with reduced risk of increased bleeding times
|
US7138412B2
(en)
|
2003-03-11 |
2006-11-21 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives useful as serine protease inhibitors
|
US7129264B2
(en)
|
2003-04-16 |
2006-10-31 |
Bristol-Myers Squibb Company |
Biarylmethyl indolines and indoles as antithromboembolic agents
|
AU2004263508A1
(en)
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
US7417063B2
(en)
|
2004-04-13 |
2008-08-26 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles useful as serine protease inhibitors
|
US7429604B2
(en)
|
2004-06-15 |
2008-09-30 |
Bristol Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
US7453002B2
(en)
|
2004-06-15 |
2008-11-18 |
Bristol-Myers Squibb Company |
Five-membered heterocycles useful as serine protease inhibitors
|
US20100190688A1
(en)
|
2004-07-12 |
2010-07-29 |
Bin Chao |
Tetrapeptide analogs
|
WO2006076575A2
(en)
|
2005-01-13 |
2006-07-20 |
Bristol-Myers Squibb Company |
Substituted biaryl compounds as factor xia inhibitors
|
US20060183771A1
(en)
|
2005-02-17 |
2006-08-17 |
Seiffert Dietmar A |
Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors
|
US20070111947A1
(en)
|
2005-10-14 |
2007-05-17 |
Mcmurry Thomas J |
Fibrin targeted therapeutics
|
JP4955009B2
(ja)
|
2005-11-11 |
2012-06-20 |
エフ.ホフマン−ラ ロシュ アーゲー |
凝固因子Xaの阻害剤としての炭素環式縮合環アミン
|
JP2009519966A
(ja)
|
2005-12-14 |
2009-05-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
セリンプロテアーゼ阻害剤として有用な6員ヘテロ環
|
US8466295B2
(en)
|
2005-12-14 |
2013-06-18 |
Bristol-Myers Squibb Company |
Thiophene derivatives as factor XIa inhibitors
|
ATE511502T1
(de)
|
2005-12-14 |
2011-06-15 |
Bristol Myers Squibb Co |
Arylpropionamid-, arylacrylamid-, arylpropinamid- oder arylmethylharnstoffanaloge als faktor-xia- inhibitoren
|
TW200745062A
(en)
|
2005-12-23 |
2007-12-16 |
Bristol Myers Squibb Co |
Macrocyclic factor VIIA inhibitors useful as anticoagulants
|
WO2008076805A2
(en)
|
2006-12-15 |
2008-06-26 |
Bristol-Myers Squibb Company |
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
|
PE20081775A1
(es)
|
2006-12-20 |
2008-12-18 |
Bristol Myers Squibb Co |
Compuestos macrociclicos como inhibidores del factor viia
|
CN101784516B
(zh)
|
2007-06-13 |
2014-07-02 |
百时美施贵宝公司 |
作为凝血因子抑制剂的二肽类似物
|
US8324199B2
(en)
|
2008-03-13 |
2012-12-04 |
Bristol-Myers Squibb Company |
Pyridazine derivatives as factor xia inhibitors
|
WO2010151317A1
(en)
|
2009-06-22 |
2010-12-29 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
WO2011002520A2
(en)
|
2009-07-02 |
2011-01-06 |
Angion Biomedica Corp. |
Small molecule inhibitors of parp activity
|
AR077695A1
(es)
|
2009-08-04 |
2011-09-14 |
Schering Corp |
Derivados de pirimidina como inhibidores del factor ixa
|
CA2789622C
(en)
*
|
2010-02-11 |
2018-04-03 |
Bristol-Myers Squibb Company |
Macrocycles as factor xia inhibitors
|
WO2013009527A2
(en)
|
2011-07-08 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
TW201319068A
(zh)
*
|
2011-08-05 |
2013-05-16 |
必治妥美雅史谷比公司 |
作為xia因子抑制劑之環狀p1接合劑
|
TW201311689A
(zh)
|
2011-08-05 |
2013-03-16 |
必治妥美雅史谷比公司 |
作為因子xia抑制劑之新穎巨環化合物
|
JP6033318B2
(ja)
|
2011-10-14 |
2016-11-30 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
第XIa因子阻害剤としての置換テトラヒドロイソキノリン化合物
|
AU2012322085B2
(en)
|
2011-10-14 |
2017-05-04 |
Bristol-Myers Squibb Company |
Substituted tetrahydroisoquinoline compounds as factor Xia inhibitors
|
EP2766345B1
(en)
|
2011-10-14 |
2016-03-16 |
Bristol-Myers Squibb Company |
Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
|
GB2497806A
(en)
|
2011-12-21 |
2013-06-26 |
Ono Pharmaceutical Co |
Pyridinone and pyrimidinone derivatives as factor XIa inhibitors
|
NO2794597T3
(sr)
|
2011-12-21 |
2018-04-14 |
|
|
EP2807156A1
(en)
|
2012-01-27 |
2014-12-03 |
Novartis AG |
Aminopyridine derivatives as plasma kallikrein inhibitors
|
WO2013111108A1
(en)
|
2012-01-27 |
2013-08-01 |
Novartis Ag |
5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
3位置換プロリン誘導体
|
AU2013258043B2
(en)
|
2012-05-10 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Antibodies capable of binding to the coagulation factor XI and/or its activated form factor XIa and uses thereof
|
GB201209138D0
(en)
|
2012-05-24 |
2012-07-04 |
Ono Pharmaceutical Co |
Compounds
|
TW201416362A
(zh)
|
2012-07-19 |
2014-05-01 |
Dainippon Sumitomo Pharma Co |
1-(環烷基羰基)脯胺酸衍生物
|
JP6082463B2
(ja)
|
2012-08-03 |
2017-02-15 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
第xia因子阻害剤としてのジヒドロピリドンp1
|
WO2014022766A1
(en)
*
|
2012-08-03 |
2014-02-06 |
Bristol-Myers Squibb Company |
Dihydropyridone p1 as factor xia inhibitors
|
US9315519B2
(en)
|
2012-10-12 |
2016-04-19 |
Bristol-Myers Squibb Company |
Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
|
ES2668318T3
(es)
|
2012-10-12 |
2018-05-17 |
Bristol-Myers Squibb Company |
Formas cristalinas de inhibidor del factor XIa
|
US9403774B2
(en)
|
2012-10-12 |
2016-08-02 |
Bristol-Myers Squibb Company |
Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
|
US9708308B2
(en)
|
2012-12-19 |
2017-07-18 |
Merck Sharp Dohme Corp. |
Factor IXa inhibitors
|
GB201300304D0
(en)
|
2013-01-08 |
2013-02-20 |
Kalvista Pharmaceuticals Ltd |
Benzylamine derivatives
|
GB2510407A
(en)
|
2013-02-04 |
2014-08-06 |
Kalvista Pharmaceuticals Ltd |
Aqueous suspensions of kallikrein inhibitors for parenteral administration
|
EP2978751B1
(en)
|
2013-03-25 |
2018-12-05 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
|
TWI633089B
(zh)
|
2013-03-28 |
2018-08-21 |
拜耳製藥股份有限公司 |
經取代的酮基吡啶衍生物
|
WO2015011087A1
(de)
|
2013-07-23 |
2015-01-29 |
Bayer Pharma Aktiengesellschaft |
Substituierte oxopyridin-derivate und ihre verwendung als faktor xia / plasma
|
EP3049394A1
(de)
|
2013-09-26 |
2016-08-03 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenylalanin-derivate als faktor xia modulatoren
|
US20160280699A1
(en)
|
2013-09-26 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Substituted phenylalanine derivatives
|
US20160222056A1
(en)
|
2013-09-26 |
2016-08-04 |
Bayer Pharma Aktiengesellschaft |
Substituted phenylalanine derivatives
|
US20160237067A1
(en)
|
2013-09-26 |
2016-08-18 |
Bayer Pharma Aktiengesellschaft |
Substituted phenylalanine derivatives
|
EP3049410A1
(de)
|
2013-09-26 |
2016-08-03 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenylalanin-derivate als faktor xia modulatoren
|
EP3049406A1
(de)
|
2013-09-26 |
2016-08-03 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenylalanin-derivate und ihre verwendung zur behandlung von thrombotischen / thromboembolischen erkrankungen
|
TW201605809A
(zh)
|
2013-09-26 |
2016-02-16 |
拜耳製藥股份有限公司 |
經取代苯丙胺酸衍生物(一)
|
AP2016009095A0
(en)
|
2013-09-26 |
2016-03-31 |
Bayer Pharma AG |
Substituted phenylalanine derivatives
|
US20160229839A1
(en)
|
2013-09-27 |
2016-08-11 |
Merck Sharp & Dohme Corp. |
Factor XIa Inhibitors
|
EP3054944B1
(en)
|
2013-10-07 |
2019-12-04 |
Merck Sharp & Dohme Corp. |
Factor xia inhibitors
|
JP6337750B2
(ja)
|
2013-11-22 |
2018-06-06 |
小野薬品工業株式会社 |
化合物
|
WO2015107724A1
(ja)
|
2014-01-14 |
2015-07-23 |
大日本住友製薬株式会社 |
縮合5-オキサゾリジノン誘導体
|
NO2760821T3
(sr)
|
2014-01-31 |
2018-03-10 |
|
|
JP6464176B2
(ja)
|
2014-01-31 |
2019-02-06 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
芳香族p2’基を有する第xia因子阻害剤としてのマクロ環
|
EP4309653A1
(en)
|
2014-02-07 |
2024-01-24 |
Exithera Pharmaceuticals Inc. |
Therapeutic compounds and compositions
|
US9676723B2
(en)
|
2014-02-11 |
2017-06-13 |
Merck Sharp & Dohme Corp |
Factor XIa inhibitors
|
WO2015123090A1
(en)
|
2014-02-11 |
2015-08-20 |
Merck Sharp & Dohme Corp. |
Factor xia inhibitors
|
EP3104703B1
(en)
|
2014-02-11 |
2020-11-18 |
Merck Sharp & Dohme Corp. |
Factor xia inhibitors
|
CN105829298B
(zh)
|
2014-02-14 |
2019-02-01 |
四川海思科制药有限公司 |
一种吡啶酮或嘧啶酮衍生物、及其制备方法和应用
|
AU2015226855C1
(en)
|
2014-03-07 |
2021-02-11 |
Biocryst Pharmaceuticals, Inc. |
Human plasma kallikrein inhibitors
|
US9808445B2
(en)
|
2014-04-16 |
2017-11-07 |
Merck Sharp & Dohme Corp. |
Factor IXa inhibitors
|
WO2015160636A1
(en)
|
2014-04-16 |
2015-10-22 |
Merck Sharp & Dohme Corp. |
Factor ixa inhibitors
|
KR20150136294A
(ko)
|
2014-05-27 |
2015-12-07 |
주식회사 레고켐 바이오사이언스 |
인자 XIa 억제 활성을 가지는 신규한 화합물
|
CN106413710A
(zh)
|
2014-05-28 |
2017-02-15 |
默沙东公司 |
因子XIa抑制剂
|
US10138236B2
(en)
|
2014-09-24 |
2018-11-27 |
Bayer Pharma Aktiengesellschaft |
Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
|
US9453018B2
(en)
|
2014-10-01 |
2016-09-27 |
Bristol-Myers Squibb Company |
Pyrimidinones as factor XIa inhibitors
|
NO2721243T3
(sr)
|
2014-10-01 |
2018-10-20 |
|
|
KR102525392B1
(ko)
|
2014-12-10 |
2023-04-24 |
오노 야꾸힝 고교 가부시키가이샤 |
디히드로인돌리지논 유도체
|
WO2016205482A1
(en)
|
2015-06-19 |
2016-12-22 |
Bristol-Myers Squibb Company |
Diamide macrocycles as factor xia inhibitors
|